PharmaShots | Incisive News in 3 Shots

Subscribe Now

Three on-Hodgkin

Celltrion's Truxima (rituximab-abbs) Receives FDA's Approval for Three on-Hodgkin's Lymphoma Indications

Celltrion's Truxima (rituximab-abbs) Receives FDA's Approval for Three on-Hodgkin's Lymphoma Indications

November 25, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us